Aimei Health Technology Co., Ltd
Price Action
Technical Summary
CONSOLIDATINGAimei Health Technology Co., Ltd is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 45), showing significant lag compared to the market leaders. Earnings contraction of 30% provides fundamental context to the price action. Investors should exercise caution due to high volatility (173% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $34.66 | -20.54% | BELOW |
| 50 SMA | $39.67 | -30.58% | BELOW |
| 100 SMA | $37.46 | -26.48% | BELOW |
| 150 SMA | $39.26 | -29.86% | BELOW |
| 200 SMA | $32.36 | -14.89% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AFJK in an uptrend right now?
AFJK has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is AFJK overbought or oversold?
AFJK's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.
Is AFJK outperforming the market?
AFJK has a Relative Strength (RS) Rating of 45 out of 99. AFJK is currently lagging the broader market.
Where is AFJK in its 52-week range?
AFJK is trading at $27.54, which is 21% of its 52-week high ($130.37) and 17% above its 52-week low ($6.75).
How volatile is AFJK?
AFJK has a Beta of 0.29 and 52-week volatility of 173%. It's less volatile than the S&P 500 - generally more stable.